Maryam Lawal

Exploring the C‐Terminal Tail Dynamics: Structural and Molecular Perspectives into the Therapeutic Activities of Novel CRMP‐2 Inhibitors, Naringenin and Naringenin‐7‐O‐glucuronide, in the Treatment of Alzheimer's Disease

F. Olotu, M. Soliman, Clement Agoni, 2018, Chemistry & biodiversity.

Across the blood-brain barrier: Neurotherapeutic screening and characterization of naringenin as a novel CRMP-2 inhibitor in the treatment of Alzheimer's disease using bioinformatics and computational tools

Mahmoud E. S. Soliman, Fisayo A. Olotu, Maryam Lawal, 2018, Comput. Biol. Medicine.